NCT05860894View on ClinicalTrials.gov

Post Intensive Care Unit Atrial Fibrillation

NARecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

September 19, 2023

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Atrial FibrillationCritical Illness
Interventions
DEVICE

Implantable ECG holter device (Biomonitor3, Biotronik)

Subcutaneous implantation of ECG holder device to monitor ECG

Trial Locations (1)

25000

RECRUITING

Centre Hospitalier Universitaire de Besancon, Besançon

All Listed Sponsors
collaborator

Biotronik SE & Co. KG

INDUSTRY

lead

Centre Hospitalier Universitaire de Besancon

OTHER

NCT05860894 - Post Intensive Care Unit Atrial Fibrillation | Biotech Hunter | Biotech Hunter